** Biotech company Voyager Therapeutics' VYGR.O shares rise about 1% to $6.92 premarket
** Citigroup starts coverage on stock with "buy" rating and PT at $12
** Last week, Wedbush analyst Yun Zhong also started coverage on stock with "outperform" rating and PT at $11
** All ten brokerages rate the stock "buy" or higher; median PT on the stock is $18 - LSEG
** As of last close, stock down 18.7% YTD
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。